Markets:

Overview

News

Currencies

International

Treasuries

Indivior Pharmaceuticals, Inc. - Common Stock (NQ:INDV)

34.93 +0.19 (+0.55%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Indivior Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ

January 28, 2026

From Indivior Pharmaceuticals Inc.

Via GlobeNewswire

INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum Breakout Setup ↗

January 27, 2026

Via Chartmill

Indivior Announces Completion of Redomiciliation to the United States

January 26, 2026

From Indivior Pharmaceuticals Inc.

Via GlobeNewswire

Indivior Provides Full-Year 2026 Financial Guidance and Business Update

January 08, 2026

From Indivior Inc.

Via GlobeNewswire

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Earnings Scheduled For April 24, 2025 ↗

April 24, 2025

Via Benzinga

A Look at Indivior's Upcoming Earnings Report ↗

April 23, 2025

Via Benzinga

Mangrove Partners Loads Up Flywire With 2.9 Million Shares ↗

December 30, 2025

The new holding places Flywire outside the fund’s top five positions.

Via The Motley Fool

Topics Regulatory Compliance

INDIVIOR PLC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Breakout Setup ↗

December 29, 2025

INDIVIOR stock combines high-growth earnings momentum with a strong technical uptrend and a current bull flag setup for a potential breakout.

Via Chartmill

This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗

December 28, 2025

When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.

Via The Motley Fool

Topics Regulatory Compliance

Bardin Hill Dumps 349,000 Shares of Frontier Communicaitons Stock Worth $12.7 Million ↗

December 18, 2025

The position previously accounted for 7.48% of fund AUM as of the prior quarter.

Via The Motley Fool

Topics Initial Public Offering Regulatory Compliance

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗

December 07, 2025

A newly public real-estate platform is putting up numbers that look far more seasoned than its age.

Via The Motley Fool

Topics Regulatory Compliance

Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗

December 07, 2025

One fund just made a bold bet on a telecom stock undergoing a big transformation

Via The Motley Fool

Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗

December 07, 2025

This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years.

Via The Motley Fool

Topics Regulatory Compliance

Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗

December 07, 2025

A beaten-down diagnostics stock is quietly tightening margins and drawing fresh institutional conviction—here’s what that means for long-term investors.

Via The Motley Fool

The Remitly Reassessment: What Divisadero’s 95 Million Exit Tells Us About Digital Money Movement ↗

December 03, 2025

Divisadero’s $95 million selloff sends a message about where Remitly stands in the shifting economics of global money movement. Here’s what that signal may mean for long-term investors.

Via The Motley Fool

Here's Why Indivior Stock Soared 15% Today ↗

October 30, 2025

This company is accelerating sales growth in its key prescription medication.

Via The Motley Fool

INDIVIOR PLC (NASDAQ:INDV) Shows Top Technical and Setup Ratings for Potential Breakout ↗

October 20, 2025

INDIVIOR (INDV) shows strong technicals with a perfect 10 rating and a 9 setup score, signaling a potential breakout above $25.20 resistance.

Via Chartmill

This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

August 06, 2025

Via Benzinga

Indivior (INDV) Q2 EPS Jumps 104% ↗

August 01, 2025

Via The Motley Fool

Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursday ↗

July 31, 2025

Via Benzinga

Indivior (INDV) Q1 2025 Earnings Call ↗

April 24, 2025

Via The Motley Fool

Indivior PLC: Is This Deeply Undervalued Stock A Hidden Gem? ↗

April 13, 2025

With a strong position in a niche yet vital therapeutic area, Indivior PLC benefits from durable brand equity, a specialized distribution network, and a long runway for product innovation.

Via Talk Markets

Topics Stocks / Equities

European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat ↗

February 20, 2025

Indivior's 2025 outlook missed estimates, citing Suboxone sales erosion. The company plans $100 million in cost cuts, with $50M reinvested in Sublocade.

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

February 20, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

October 11, 2024

Via Benzinga

S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results ↗

October 10, 2024

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 10, 2024

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.